Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tianli Hui
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
Numerical Investigation on the Interlayer Surface Strength Effects in Carbon/Epoxy Composite Laminates Subjected to Low-Velocity Impact
Related publications
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
The Influence of Obesity on Results of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Polski Przeglad Chirurgiczny
Medicine
Surgery
Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
Docetaxel, Doxorubicin and Cyclophospharmide as Neoadjuvant Chemotherapy With Primary Prophylactic Stem Cell Growth Factor Support in Locally Advanced Breast Cancer (T3 – T4 , No – 3, Mo)
Research in Oncology
Prolonged Neoadjuvant Chemotherapy With GM‐CSF in Locally Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Survival Benefit of Neoadjuvant Chemotherapy With S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
Annals of Surgical Oncology
Oncology
Surgery
Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer
Genetic Testing and Molecular Biomarkers
Medicine
Genetics
Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer: Neoadjuvant FOLFOXIRI Chemotherapy Followed by Short-Course Radiation and Consolidated XELOX Chemotherapy Prior to Resection
Integrative Clinical Medicine
Risk Factors Affecting Breast Cancer-Related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane
Clinical Breast Cancer
Cancer Research
Oncology
